FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/075066 [Registered on: 10/10/2024] Trial Registered Prospectively
Last Modified On: 13/08/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of Virechana and Kulattha Guda in Shwasa Rog (BRONCHIAL ASTHMA)  
Scientific Title of Study   A CLINICAL STUDY ON THE EFFECT OF VIRECHANA KARMA AND KULATTHA GUDA IN THE MANAGEMENT OF TAMAK SHWASA (BRONCHIAL ASTHMA)  
Trial Acronym  Tamak Shwasa 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ayushi Srivastava 
Designation  PG SCHOLAR 
Affiliation  GOVERNMENT AYURVEDA COLLEGE AND HOSPITAL VARANASI 
Address  Department of Panchakarma Room No 11 Government Ayurveda College and Hospital Varanasi
Department of Panchakarma Room No 11 Government Ayurveda College and Hospital Varanasi
Varanasi
UTTAR PRADESH
221002
India 
Phone  08349161526  
Fax    
Email  ayushisrivastava7570@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Manish Mishra 
Designation  Reader 
Affiliation  GOVERNMENT AYURVEDA COLLEGE AND HOSPITAL VARANASI 
Address  Department of Kayachikitsa and Panchakarma Room No 11 Government Ayurveda College and Hospital Varanasi
Department of Kayachikitsa and Panchakarma Room No 11 Government Ayurveda College and Hospital Varanasi
Varanasi
UTTAR PRADESH
221002
India 
Phone  9415896482  
Fax    
Email  manish.arnav@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ayushi Srivastava 
Designation  PG SCHOLAR 
Affiliation  GOVERNMENT AYURVEDA COLLEGE AND HOSPITAL VARANASI 
Address  Department of Panchakarma Room No 11 Government Ayurveda College and Hospital Varanasi
Department of Panchakarma Room No 11 Government Ayurveda College and Hospital Varanasi
Varanasi
UTTAR PRADESH
221002
India 
Phone  08349161526  
Fax    
Email  ayushisrivastava7570@gmail.com  
 
Source of Monetary or Material Support  
Goverment PG Ayureda College AND Hospital Varanasi 221002 UP India 
 
Primary Sponsor  
Name  Goverment PG Ayureda College AND Hospital Varanasi 221002 UP India  
Address  Goverment PG Ayureda College AND Hospital Varanasi 221002 UP India  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ayushi Srivastava  Government P.G. Ayurveda College and Hospital Varanasi  Department of Panchakarma, Government P.G Ayurveda College and Hospital 221002 VARANASI UTTAR PRADESH
Varanasi
UTTAR PRADESH 
8349161526

ayushisrivastava7570@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC, Government Ayurveda College and Hospital Varanasi U.P., Mahayogi Guru Gorakhnath AYUSH University, Gorakhpur, U.P.  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J452||Mild intermittent asthma. Ayurveda Condition: TAMAKASVASAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-virecana-karma, विरेचन-कर्म (Procedure Reference: CHARAK SAMHITA CHIKITSASTHANA 17/12, Procedure details: Patient will be administered snehpana for 5-7 days followed by swedana.Then virechana aushadh will be administered followed by samsarjana karma. )
(1) Medicine Name: Aragvadhaphala Majja, Reference: charak sutra 25/40, Route: Oral, Dosage Form: Kwatha/Kashaya, Dose: 100(ml), Frequency: od, Duration: 1 Days
2Comparator ArmDrugClassical(1) Medicine Name: KULATTHA GUDA, Reference: CHAKRADATT CHIKITSA 12/31-34, Route: Oral, Dosage Form: Avleha/Leha/Paka/Raskriya, Dose: 10(g), Frequency: bd, Bhaishajya Kal: Antarabhakta, Duration: 21 Days, anupAna/sahapAna: Yes(details: -USHNA JALA), Additional Information: -
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  â–ª Patients with classical signs and symptoms of Tamak Shwasa will be taken
for the study.
â–ª Patients between age group 16-60yrs
â–ª Patients irrespective of sex, religion,socio economic status, occupation and
habitat.
â–ª Patients having chronicity less than one year.
â–ª Patients who are Yogya of Virechana Karma. 
 
ExclusionCriteria 
Details  Patients suffering from major systemic disorders, cardiac asthma, chronic
renal failure, topical pulmonary eosinophilia, tuberculosis, emphysema,
COPD, spontaneous pneumothorax, complicated bronchial asthma, lower
respiratory tract infections e.g ARDS, pneumonitis, hypertension, diabetes
mellitus, thyroid, pregnant women and lactating mothers.
â–ª Age less than 16 and more than 60 yrs.
â–ª Patients on drug dependence.
â–ª Patients having chronicity more than one year.
â–ª Patients Ayogya of Virechana.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Mild relief in swasakashtata, kasa, ghurghurkam, urah parshwa peedyena   15 days 
 
Secondary Outcome  
Outcome  TimePoints 
Complete relief in the Chief complaints of Tamak Shwasa & also Effective in Jwara Kasa & Hikka  35 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "60"
Final Enrollment numbers achieved (India)="60" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   20/10/2024 
Date of Study Completion (India) 14/05/2026 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
This study is an Open Randomized Comparative and Interventional Group Study trial on topic of A CLINICAL STUDY OF EFFECT OF VIRECHANA KARMA AND KULATTHA GUDA IN THE MANAGEMENT OF TAMAK SHWASA (BRONCHIAL ASTHAMA). This study includes 60 no. of patients,divided into two groups.
GROUP A
30 Patients treated with Virechana Karma with the help of Aragvadha Phala Majja, in duration of 21 days.
GROUP B 
30 Patients treated with Kulattha Guda, in duration of 21 days.
After completion of treatment course, there were two follow up with the interval of 7 days.
First Follow Up at 7th day
Second Follow Up at 14th day.    
Result obtained after statistical analysis:
Group A: In this group, out of 30, maximum 14 patients (46.67%) got good improvement, while 15
patients (50%) got moderate improvement and 01 patient (03.33%) got mild improvement in overall subjective and objective parameters.

Group B: In this group, out of 30, maximum 19 patient (16.67%) got good improvement while
19 patients (63.33%) got moderate improvement and 06 patients (20%) got mild improvement in overall subjective and objective parameters.

Conclusion: Statistically significant difference was observed in trial group (Group-A) as compared to
control group (Group-B) in terms of Shwasakastata, kasa, Ghurghurkam, Urah Parshwa Cha Peedyena, Lalate Swedana, Aseeno Labahte Saukhyam, TLC, ESR, AEC, S.IgE, FEV1, FVC, FEV1/EVC
 
Close